AngioDynamics to Report Fiscal Second Quarter 2009 Financial Results and Hold Conference Call on January 6, 2009 QUEENSBURY, N.Y.--(BUSINESS WIRE)-- Dec. 16, 2008 -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists,

AngioDynamics Appoints Vice President, Regulatory, Quality and Clinical Affairs QUEENSBURY, N.Y.--(BUSINESS WIRE)-- Dec. 9, 2008 -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally

AngioDynamics To Participate in Panel Discussion at RBC 2008 Healthcare Conference QUEENSBURY, N.Y., Dec 04, 2008 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally

AngioDynamics Implements Leadership Development Plan and Reports Preliminary Fiscal Second Quarter Financial Results QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 3, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons

New NanoKnife(TM) System Used to Perform Three Cases

AngioDynamics to Launch VenaCure EVLT(TM), New Brand for Varicose Vein Treatment AngioDynamics to Launch VenaCure EVLT(TM), New Brand for Varicose Vein Treatment QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 6, 2008--AngioDynamics Inc. (NASDAQ:ANGO) today announced it will launch a new varicose vein

Charles Orsatti Elected to AngioDynamics' Board of Directors QUEENSBURY, N.Y.--(BUSINESS WIRE)-- October 24, 2008 AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and

AngioDynamics Reports Financial Results for Fiscal First Quarter 2009 -- Net Sales Increase 18% to $44.3 Million QUEENSBURY, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the

AngioDynamics to Hold Fiscal First Quarter Earnings Conference Call on October 2, 2008 QUEENSBURY, N.Y.--(BUSINESS WIRE)--Sept. 12, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the

AngioDynamics to Present at Canaccord Adams 28th Annual Global Growth Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 5, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally

AngioDynamics Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results -- Fourth Quarter Sales Increase 14% to $46.8 Million -- Net Income for the Fourth Quarter of $519,000 and EPS of $0.02; Excluding VNUS Medical Settlement, Net Income of $4.7 Million and EPS of $0.19 -- Adjusted Income

AngioDynamics Appoints Vice President of International IRE Sales QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 23, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment

AngioDynamics Appoints Senior Vice President of Business Development AngioDynamics Appoints Senior Vice President of Business Development QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 17, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional

AngioDynamics to Hold Fiscal Fourth Quarter and Full-Year 2008 Financial Results Conference Call on July 24, 2008 QUEENSBURY, N.Y., Jul 15, 2008 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists

Radiofrequency Ablation Yields High Proportions of Sustained Complete Responses in Patients with Lung Cancer Study Shows Confirmed, Complete Response in 88% of Patients After 1 Year QUEENSBURY, N.Y.--(BUSINESS WIRE)--July 14, 2008--AngioDynamics (NASDAQ:ANGO) announced today results from its

AngioDynamics Initiates Voluntary Recall of its Centros Catheter QUEENSBURY, N.Y., Jul 10, 2008 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment

AngioDynamics Completes Acquisition of U.S. and U.K. Diomed Assets QUEENSBURY, N.Y.--(BUSINESS WIRE)--June 18, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive

AngioDynamics Reports Preliminary Net Sales for Fiscal Fourth Quarter and Fiscal Year 2008 QUEENSBURY, N.Y.--(BUSINESS WIRE)--June 5, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the

AngioDynamics Purchase of Certain Diomed Assets in the United States Approved by Bankruptcy Court Acquisition of Certain Diomed Assets in the United States and the United Kingdom Expected to Close on or About June 16, 2008 Transaction to Strengthen AngioDynamics' Presence in Endovenous Laser Market

AngioDynamics Announces Settlement of Patent Litigation With VNUS Medical Technologies AngioDynamics Announces Settlement of Patent Litigation With VNUS Medical Technologies QUEENSBURY, N.Y.--(BUSINESS WIRE)--June 3, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical